Frank Steven (CIK 1583886) reported 11 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-06-02). Recent activity: Buy BCRX (1,262 shares), Buy PGEN (71,839 shares), Buy PGEN (14,245 shares), Buy BCRX (1,285 shares), Buy BCRX (1,566 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-02 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Director | Buy | 1,262 | $11,244 |
| 2026-03-16 | PRECIGEN, INC. (PGEN) | Director | Buy | 71,839 | $0 |
| 2026-03-12 | PRECIGEN, INC. (PGEN) | Director | Buy | 14,245 | $50,000 |
| 2026-03-03 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Director | Buy | 1,285 | $11,244 |
| 2025-12-02 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Director | Buy | 1,566 | $11,244 |
| 2025-09-03 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Director | Buy | 1,353 | $11,243 |
| 2025-06-16 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Director | Buy | 12,500 | $0 |
| 2025-06-03 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Director | Buy | 333 | $3,580 |
| 2025-05-06 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Director | Buy | 1,866 | $0 |
| 2025-03-17 | PRECIGEN, INC. (PGEN) | Director | Buy | 28,735 | $49,999 |
| 2025-03-17 | PRECIGEN, INC. (PGEN) | Director | Buy | 87,412 | $0 |
Source: SEC Form 4 filings · as of 2026-06-02